^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Glioma
    Drug:Avastin (bevacizumab) (VEGF-A inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Anaplastic Glioma...Other Recommended Regimens...Carmustine or lomustine + bevacizumab...TMZ + bevacizumab.
    Secondary therapy:
    carmustine; temozolomide; lomustine